These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3423747)

  • 1. Enterobacter meningitis--treatment complicated by emergence of mutants resistant to cefotaxime.
    Ralph ED; Behme RJ
    Scand J Infect Dis; 1987; 19(5):577-9. PubMed ID: 3423747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of resistance to multiple beta-lactams in Enterobacter cloacae during treatment for neonatal meningitis with cefotaxime.
    Heusser MF; Patterson JE; Kuritza AP; Edberg SC; Baltimore RS
    Pediatr Infect Dis J; 1990 Jul; 9(7):509-12. PubMed ID: 2371083
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment failures of cefotaxime and latamoxef in meningitis caused by Enterobacter and Serratia spp.
    Eng RH; Cherubin CE; Pechere JC; Beam TR
    J Antimicrob Chemother; 1987 Dec; 20(6):903-11. PubMed ID: 3501999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of enhanced cefotaxime resistance in Enterobacter spp.
    Hopkins JM; Towner KJ; Slack RC; Harper PB; Simpson IN
    J Antimicrob Chemother; 1987 Oct; 20(4):489-96. PubMed ID: 3500163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of cefotaxime-resistant Enterobacter during therapy of cardiac surgery patients.
    Weinstein RA
    Chemioterapia; 1985 Feb; 4(1):110-2. PubMed ID: 3986939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria].
    Lazăr V; Cernat R; Balotescu C; Cotar A; Coipan E; Cojocaru C
    Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):185-91. PubMed ID: 15085610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad-spectrum beta-lactam resistance in Enterobacter: emergence during treatment and mechanisms of resistance.
    Olson B; Weinstein RA; Nathan C; Kabins SA
    J Antimicrob Chemother; 1983 Apr; 11(4):299-310. PubMed ID: 6602122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment with a cefotaxime-fosfomycin combination of staphylococcal or enterobacterial meningitis in adults].
    Portier H; Armengaud M; Becq-Giraudon B; Bousser J; Desbordes JM; Duez JM; Kazmierczak A; Korinek AM; Laisne MJ; Pangon B
    Presse Med; 1987 Dec; 16(43):2161-6. PubMed ID: 2963304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of resistance to ceftazidime during therapy for Enterobacter cloacae infections.
    Quinn JP; DiVincenzo CA; Foster J
    J Infect Dis; 1987 May; 155(5):942-7. PubMed ID: 3549922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefotaxime and aminoglycoside treatment of meningitis caused by gram-negative enteric organisms.
    Kaplan SL; Patrick CC
    Pediatr Infect Dis J; 1990 Nov; 9(11):810-4. PubMed ID: 2263430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five years of cefotaxime use in a neonatal intensive care unit.
    Spritzer R; vd Kamp HJ; Dzoljic G; Sauer PJ
    Pediatr Infect Dis J; 1990 Feb; 9(2):92-6. PubMed ID: 2179846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of cefotaxime in gram-negative meningitis.
    LeFrock JL; Molavi A; Smith B; Black P; Rosenberg M; Rolston K; Brodner R; Chandrasekar P; Henao L; Kannangara DW
    Neurosurgery; 1984 Nov; 15(5):679-82. PubMed ID: 6095133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enterobacteriaceae meningitis treated with cefotaxime].
    Guerrero A; Pérez-Gorricho B; Loza E; Ludeña-Carpio MC; Bustos JC; Bouza E
    Rev Clin Esp; 1986 Apr; 178(7):319-21. PubMed ID: 3738001
    [No Abstract]   [Full Text] [Related]  

  • 14. Cefotaxime therapy of neonatal gram-negative bacillary meningitis.
    Naqvi SH; Maxwell MA; Dunkle LM
    Pediatr Infect Dis; 1985; 4(5):499-502. PubMed ID: 3900946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of cefotaxime resistance during treatment].
    Søgaard P
    Ugeskr Laeger; 1986 Jan; 148(5):260-1. PubMed ID: 3952856
    [No Abstract]   [Full Text] [Related]  

  • 16. Gentamicin vs cefotaxime for therapy of neonatal sepsis. Relationship to drug resistance.
    Bryan CS; John JF; Pai MS; Austin TL
    Am J Dis Child; 1985 Nov; 139(11):1086-9. PubMed ID: 3904403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and microbiologic characteristics of cefotaxime-non-susceptible Enterobacteriaceae bacteremia: a case control study.
    Noguchi T; Matsumura Y; Yamamoto M; Nagao M; Takakura S; Ichiyama S
    BMC Infect Dis; 2017 Jan; 17(1):44. PubMed ID: 28061869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The origin, by mutation, of high level resistance to ceftazidime and cefotaxime in a clinical isolate of Enterobacter cloacae.
    Blahová J; Lesická-Hupková M; Králiková K; Krcméry V; Mikovicová A
    J Chemother; 1996 Aug; 8(4):266-9. PubMed ID: 8873831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal beta-lactamase expression and antibiotic resistance in Enterobacter cloacae.
    Yang YJ; Livermore DM; Williams RJ
    J Med Microbiol; 1988 Mar; 25(3):227-33. PubMed ID: 3258037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Enterobacter cloacae and E. aerogenes septicemia: emergence of resistant variants (derepressed cephalosporinase) during treatment with third-generation cephalosporins].
    Nauciel C; Philippon A; Ronco E; Pilliot J; Guenounou M; Paul G; Brunel D; Outin HD
    Presse Med; 1985 Mar; 14(12):673-6. PubMed ID: 3157961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.